4.5 Article

A human serotonin transporter mutation causes constitutive activation of transport activity

期刊

MOLECULAR PHARMACOLOGY
卷 64, 期 2, 页码 440-446

出版社

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.64.2.440

关键词

-

向作者/读者索取更多资源

A rarely occurring variant of human serotonin transporter (hSERT) was tested for its functional consequences in HeLa and COS-7 cells. The variant, in which Ile-425 is converted to Val, was significantly different from wild type with respect to its catalytic properties. In both cell types, rates of serotonin (5-HT) transport were higher for the I425V variant. Both an increase in V-max and a decrease in K-M caused this increase in rate. The increase in V-max was not accounted for by increases in transporter expression or in the distribution of transporter between the cell surface and intracellular pools. The decrease in K-M was accompanied by a decrease in the K-D for binding of the cocaine analog 2beta-carbomethoxy-3beta- (4-[I-125] iodophenyl) tropane. In both HeLa and COS-7 cells, the nitric oxide donor S-nitroso-N-acetylpenicillamine increased the activity of wild-type hSERT to that of the variant but did not change the activity of the I425V variant. This stimulation was prevented by the presence of oxyhemoglobin, which quenches nitric oxide, and by an inhibitor of guanylyl cyclase.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据